A trial of targeted drugs for bile duct cancer and gallbladder cancer (SAFIR-ABC10)
This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of the body or has come back after treatment
This trial is looking at targeted drugs for bile duct cancer and gallbladder cancer that has spread to another part of the body or has come back after treatment
This trial is looking at a programme to help people lose weight before surgery for bowel cancer.
This trial is looking at whether it is possible to give pembrolizumab less often for advanced non small lung cancer.
This trial is looking at whether a blood test can find cancer that has come back before doctors can see it on a scan.
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
This trial is looking at adding a drug called inavolisib to palbociclib and fulvestrant for breast cancer.
This trial is comparing giredestrant and palbociclib with letrozole and palbociclib for breast cancer.
This trial is trying to find out if giredestrant (GDC-9545) works better than other hormone therapies for locally advanced or secondary breast cancer.
This study is looking at blood and tissue samples in people having their first treatment for B cell lymphoma.
This trial is looking at adding durvalumab to chemoradiotherapy for people with bladder cancer that has grown into the muscle wall.